RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
NCEs, new patented formulations and products
Respiratory; women's care; dermatology; pain relief; GI More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Emerging Technologies: Stem cells
Nov 2011 - 61 pages - $3,800
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Company Financials: Acorda Therapeutics, Inc.
Jan 2010 - $75
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
MarketWatch: Health Round-up
Dec 2008 - 50 pages - $400
Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $250
Groupe Forenap - Strategic SWOT Analysis Review
May 2011 - 18 pages - $125
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us